GlassScriptPhysician profile
Jonathan C Lohrbach
NPI 1679670632
$58,184.76
in general payments reported to CMS, 2019-2025
34 companies · $16K in 2025
The $16K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,094 · 2020: $3,323 · 2021: $2,489 · 2022: $5,624 · 2023: $14K · 2024: $15K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $28K · Food and Beverage: $6,688 · Travel and Lodging: $4,869 · Honoraria: $4,800 · Education: $72.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,225.00 |
| Food and Beverage | $6,687.74 |
| Travel and Lodging | $4,869.49 |
| Honoraria | $4,800.00 |
| Education | $72.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $24,700.00 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $11,481.52 | 2019-2025 | Exparel, Iovera, Zilretta |
| Baxter Healthcare | $7,393.98 | 2019-2025 | Perclot, Floseal, Preveleak |
| Intuitive Surgical, INC. | $5,140.48 | 2019-2025 | Da Vinci Surgical System |
| Stryker Corporation | $4,066.45 | 2021-2025 | 1788, 1688, Spy-Phi System |
| Tela Bio, INC. | $1,144.94 | 2022-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Ethicon Endo-Surgery INC. | $1,100.00 | 2022 | |
| Davol INC. | $664.04 | 2019-2025 | Phasix Mesh |
| Medtronic, INC. | $436.23 | 2021-2025 | Endoflip, Ligasure, Dextile |
| Merck Sharp & Dohme LLC | $326.59 | 2019-2025 | Bridion |
| Smith+Nephew, INC. | $310.99 | 2019-2024 | Grafix Pl, Pico 14, Pico |
| Kci USA, INC. | $183.92 | 2019-2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo |
| Merit Medical Systems INC | $133.07 | 2025 | Savi Scout |
| Integra Lifesciences Corporation | $122.79 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Kerecis Limited | $114.66 | 2020-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stability Biologics, LLC | $97.92 | 2020-2021 | |
| Ets Wound Care LLC | $86.95 | 2024-2025 | Mirragen Advanced Wound Matrix |
| Innocoll Pharmaceuticals Limited | $86.56 | 2021-2022 | |
| Hydrofera LLC | $82.53 | 2024 | Hydrofera Blue, Cutimed Sorbion |
| Organogenesis INC. | $66.52 | 2020-2022 | |
| Ethicon US, LLC | $66.15 | 2022-2024 | Stratafix, Ethicon |
| Solventum Corporation | $63.59 | 2024-2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo Cleanse Choice |
| Conmed Corporation | $60.44 | 2023 | Airseal |
| Focal Therapeutics, INC. | $48.99 | 2019-2020 | |
| Mimedx Group, INC. | $33.06 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $26.20 | 2024 | Myrisk |
| Acell, INC. | $25.97 | 2020 | |
| Sanara Medtech INC. | $20.51 | 2025 | Celleraterx |
| Acera Surgical, INC. | $20.31 | 2024 | Restrata Wound Matrix |
| Convatec INC. | $20.07 | 2025 | |
| Teleflex LLC | $16.24 | 2019 | |
| Bioventus LLC | $15.29 | 2022 | |
| Medline Industries LP | $14.48 | 2019 | |
| Bioptics, INC. | $13.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lohrbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.